制备和硼氢化物还原的-2,3-二脱氧-5,6- ö异丙叉基-2'-苯基- d -allofuranoso- [2,3- d ]-Δ 2' -恶唑啉(XXI)中描述。还原产物是2-氨基-2-脱氧-D-烯丙醇的衍生物,表明在化合物(XXI)的形成和还原过程中未发生糖系统的异构化。由2-氨基-2-脱氧-D-葡萄糖呋喃糖的苯并恶唑啉衍生物合成了具有还原的侧链的山mic酸的衍生物。还开发了一种方便的制备1,2- O-异亚丙基-D-葡萄糖呋喃糖和相关糖类的5,6-碳酸酯的方法。
制备和硼氢化物还原的-2,3-二脱氧-5,6- ö异丙叉基-2'-苯基- d -allofuranoso- [2,3- d ]-Δ 2' -恶唑啉(XXI)中描述。还原产物是2-氨基-2-脱氧-D-烯丙醇的衍生物,表明在化合物(XXI)的形成和还原过程中未发生糖系统的异构化。由2-氨基-2-脱氧-D-葡萄糖呋喃糖的苯并恶唑啉衍生物合成了具有还原的侧链的山mic酸的衍生物。还开发了一种方便的制备1,2- O-异亚丙基-D-葡萄糖呋喃糖和相关糖类的5,6-碳酸酯的方法。
3-d]-Δ2′-oxazoline (XXI) are described. The reduction product was a derivative of 2-amino-2-deoxy-D-allitol, indicating that no isomerisation of the sugar system in compound (XXI) had occurred during its formation and reduction. A derivative of muramic acid containing a reduced side chain was synthesised from a phenyloxazolinederivative of 2-amino-2-deoxy-D-glucofuranose. A convenient method for the preparation
制备和硼氢化物还原的-2,3-二脱氧-5,6- ö异丙叉基-2'-苯基- d -allofuranoso- [2,3- d ]-Δ 2' -恶唑啉(XXI)中描述。还原产物是2-氨基-2-脱氧-D-烯丙醇的衍生物,表明在化合物(XXI)的形成和还原过程中未发生糖系统的异构化。由2-氨基-2-脱氧-D-葡萄糖呋喃糖的苯并恶唑啉衍生物合成了具有还原的侧链的山mic酸的衍生物。还开发了一种方便的制备1,2- O-异亚丙基-D-葡萄糖呋喃糖和相关糖类的5,6-碳酸酯的方法。